On the armament and appearances of human myeloid-derived suppressor cells

被引:165
|
作者
Poschke, Isabel [1 ]
Kiessling, Rolf [1 ]
机构
[1] Karolinska Inst, Dept Pathol & Oncol, Canc Ctr Karolinska R8 01, Stockholm, Sweden
关键词
MDSC; Cancer; Autoimmunity; Transplantation; CD4(+) T-CELLS; DENDRITIC CELL; IMMUNE SUPPRESSION; CANCER-PATIENTS; ARGINASE-I; IMMUNOSUPPRESSIVE ACTIVITY; HEPATOCELLULAR-CARCINOMA; HEMATOPOIETIC STEM; ANTITUMOR IMMUNITY; HYDROGEN-PEROXIDE;
D O I
10.1016/j.clim.2012.06.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSC) have frequently been observed in patients with cancer. This heterogeneous population of myeloid cells can exert potent suppression of lymphocyte function and thereby poses a significant hurdle to natural or therapeutically induced anti-tumor immunity. On the other hand, the natural function of MDSC is not yet well understood and their role in infection, inflammation and autoimmune disease is still puzzling. Understanding MDSC biology will provide the tools necessary for therapeutic targeting of this population, but also permit exploitation of their strong tolerogenic function in the treatment of inflammatory conditions and the prevention of graft rejection. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:250 / 268
页数:19
相关论文
共 50 条
  • [41] Tumor Microenvironment and Myeloid-Derived Suppressor Cells
    Umansky, Viktor
    Sevko, Alexandra
    CANCER MICROENVIRONMENT, 2013, 6 (02) : 169 - 177
  • [42] Induction of myelodysplasia by myeloid-derived suppressor cells
    Chen, Xianghong
    Eksioglu, Erika A.
    Zhou, Junmin
    Zhang, Ling
    Djeu, Julie
    Fortenbery, Nicole
    Epling-Burnette, Pearlie
    Van Bijnen, Sandra
    Dolstra, Harry
    Cannon, John
    Youn, Je-in
    Donatelli, Sarah S.
    Qin, Dahui
    De Witte, Theo
    Tao, Jianguo
    Wang, Huaquan
    Cheng, Pingyan
    Gabrilovich, Dmitry I.
    List, Alan
    Wei, Sheng
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (11): : 4595 - 4611
  • [43] Myeloid-derived suppressor cells, age and cancer
    Bowdish, Dawn M. E.
    ONCOIMMUNOLOGY, 2013, 2 (07):
  • [44] Targeting Myeloid-Derived Suppressor Cells in Cancer
    Anani, Waseem
    Shurin, Michael R.
    TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : 105 - 128
  • [45] Myeloid-Derived Suppressor Cells in Solid Tumors
    Ma, Tianmiao
    Renz, Bernhard W.
    Ilmer, Matthias
    Koch, Dominik
    Yang, Yuhui
    Werner, Jens
    Bazhin, Alexandr V.
    CELLS, 2022, 11 (02)
  • [46] In Brief: Myeloid-derived suppressor cells in cancer
    Solito, S.
    Pinton, L.
    Mandruzzato, S.
    JOURNAL OF PATHOLOGY, 2017, 242 (01): : 7 - 9
  • [47] Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
    Bizymi, Nikoleta
    Papadaki, Helen A.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [48] MYELOID-DERIVED SUPPRESSOR CELLS IN LUNG TRANSPLANTATION
    Heigl, Tobias
    Singh, Anurag
    Saez-Gimenez, Berta
    Kaes, Janne
    vanHerck, Anke
    Sacreas, Annelore
    Beeckmans, Hanne
    Vanstapel, Arno
    Verleden, Stijn
    vanRaemdonck, Drik
    Verleden, Geert
    Vanaudenaerde, Bart
    Hartl, Dominik
    Vos, Robin
    TRANSPLANT INTERNATIONAL, 2019, 32 : 108 - 108
  • [49] Myeloid-derived Suppressor Cells and Multiple Sclerosis
    Zanghi, Aurora
    Di Filippo, Paola Sofia
    Avolio, Carlo
    D'Amico, Emanuele
    CURRENT NEUROPHARMACOLOGY, 2025, 23 (01) : 36 - 57
  • [50] Myeloid-derived suppressor cells in breast cancer
    Markowitz, Joseph
    Wesolowski, Robert
    Papenfuss, Tracey
    Brooks, Taylor R.
    Carson, William E., III
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 13 - 21